K
ϩ -Cl Ϫ cotransporter; acidosis; diabetes; low-salt diet THE ELECTRONEUTRAL MOVEMENT of K ϩ and Cl Ϫ across the plasma membrane is accomplished by a group of secondary active transport proteins known as K ϩ -Cl Ϫ cotransporters (KCCs). This transport system was originally described in red blood cells as a swelling-and N-ethylmaleimide-activated, Cl Ϫ -dependent, K ϩ efflux mechanism (11, 16, 30, 31) , with a particular role in the regulation of cell volume. When cells swell, the activation of KCCs help to eliminate ions and return the cell to its original volume, a process known as regulatory volume decrease (RVD). Later on, it was observed that KCCs are present in many tissues, in which they play important roles beyond cell volume regulation. One outstanding example is the critical role that KCC2 plays in modulating the intraneuronal Cl Ϫ concentration, which, in turn, is critical to define the response (hyperpolarizing or depolarizing) of ionotropic neurotransmitter receptor, ligand-gated Cl Ϫ channels in the postsynaptic membrane (5) .
KCCs are members of the SLC12 family of solute transporters, in which four different genes, SLC12A4 to SLC12A7, encode for KCC1-KCC4 isoforms. Three of these transporters, KCC1, KCC3, and KCC4, are expressed in several tissues, including the kidney, whereas KCC2 is neuron specific (17) . The presence of KCC1 in the kidney has been suggested only a demonstration of the presence of its mRNA transcripts (20) , whereas the presence of KCC3 and KCC4 have been identified at both mRNA and protein levels (6, 38, 40) . The expression of KCC3 protein is located in the basolateral membrane of proximal convoluted tubule (PCT) cells (38) , whereas KCC4 protein is present in the basolateral membrane of the PCT as well as in the basolateral membrane of the thick ascending limb (TAL) of Henle's loop and ␣-intercalated cells of the collecting ducts (6, 49) .
While much information regarding the role of KCCs in central nervous system physiology has been reported (5, 27, 36) , little is known about their role in renal physiology. Avison et al. (4) presented evidence for a Ba 2ϩ -insensitive but furosemide-sensitive K ϩ transport mechanism compatible with a KCC system in the basolateral membrane of PCT cells that is stimulated by increased Na ϩ -glucose transport in the apical membrane, suggesting that transcellular glucose transport requires high rates of K ϩ recycling in the basolateral membrane. Greger and Schlatter's (21) data supported the presence of an electroneutral K ϩ -Cl Ϫ cotransport system in the basolateral membrane of TAL cells. Amorim et al. (2) observed the existence of an apical K ϩ -Cl Ϫ cotransport system in distal convoluted tubule (DCT) cells that was particularly active in the presence of a low luminal Cl Ϫ concentration, suggesting that such a role could provide a K ϩ secretory pathway with a low-salt diet. Finally, the development of KCC4 knockout mice revealed that the absence of KCC4 is associated with renal tubular acidosis (6) . However, until now, none of these potential roles have been explored in animal models using molecular tools. Thus, the goal of the present work was to determine the behavior of KCC3 and KCC4 mRNA and protein expression during hyperglycemia, salt restriction, metabolic acidosis, and K ϩ diet. Our data are consistent with an important role of KCCs as cotransporters in the renal handling of glucose, salt, and protons.
METHODS
Animal models. Male Wistar rats weighing 250 -300 g or male C57 mice weighing 20 -25 g were provided by our animal facility. All animal procedures were performed in accordance with the Mexican Federal Regulation for Animal Experimentation and Care (NOM-062-ZOO-2001) and were approved by our Institutional Animal Care Committees. All rodents were housed in regular polypropylene cages with 3 animals/cage with 12:12-h light-dark cycles and at a constant temperature and humidity of 20°C and 65%, respectively. On the first and last days of the experiment, animals were placed in metabolic cages (Nalgene) to determine 24-h water intake and urinary electrolyte excretion and osmolarity. After animals were euthanasized, serum electrolytes, creatinine, and osmolarity were determined.
Experimental procedures. We studied five experimental groups. Group 1 consisted of rats given a single intraperitoneal injection of streptozotocin (STZ; 60 mg/kg body wt, Sigma) (29, 42) . Seventy-two hours after STZ administration, the blood glucose concentration was determined (Accu-Chek sensor comfort, Roche Diagnostics), and only rats with a postprandial blood glucose level of Ͼ20.0 mmol/l were considered diabetic and were followed for the next 4 wk. Animals were fed with regular NaCl rat chow (0.4% NaCl chow, no. 5001, Harlan) and tap water. As a control, we used rats treated with a single intraperitoneal injection of citrate buffer solution (0.1 M, pH 4.4) and were fed with regular chow and tap water. Group 2 was given a low NaCl intake for 8 days. This model was performed in wild-type mice and WNK4
Ϫ/Ϫ knockout mice, which have been previously described (8) . These animals were fed with low-NaCl chow (0.01-0.02% NaCl chow, TD.90228, Harlan) and tap water (8, 39) . Group 3, which consisted of both rats and mice, was given free access to a drinking solution with 280 mM NH4Cl for 8 days (1, 41) . Control animals for groups 2 and 3 consisted of rats or mice that were simultaneously carried through all procedures and fed similar amount of regular chow diet and tap water. Groups 4 and 5 consisted of mice given either a low-or high-K ϩ diet for 8 days, respectively. Control (
, and high-K ϩ (5% K ϩ ) diets were obtained from TestDiet (St. Louis, MO) and were prepared by modifying the AIN-93M semipurified diet. The low-K ϩ diet was used as a base, and tribasic potassium citrate was added to generate the control and high-K ϩ diets (8) . After a 2-day period of adaption to the control powder diet, the diet was changed to a low-or high-K ϩ diet for some animals, whereas the control group continued to receive the control diet. At the end of day 4, mice were killed, and kidneys were removed.
After each experimental treatment period, animals were anesthetized with pentobarbital sodium (50 mg/kg), and kidneys were perfused with saline solution and rapidly removed. The cortex and medulla from one kidney were isolated and frozen in liquid nitrogen, whereas the other kidney was placed in 4% paraformaldehyde to carry on the immunohistochemical assays.
Preparation of renal tissue. The cortex, medulla, or whole kidney was homogenized (0.1 g tissue/ml) in buffer solution containing 250 mM sucrose, 1 mM EDTA, 10 mM Tris·HCl buffer (pH 7.6), and a protease cocktail inhibitor complete 1 tablet per 10 ml (Roche Diagnostics). Homogenates were centrifuged at 10,000 g for 30 min at 4°C, and supernatants were used to measure the total protein expression. The protein concentration was measured with the Bradford method using BSA, as is standard with the Bio-Rad DC protein assay (Bio-Rad, Hercules, CA).
Immunoblot analysis. Western blot analysis of KCC3 and KCC4 proteins was performed using previously characterized affinity-purified rabbit polyclonal antibodies specific for the 19-residue peptides KCC3-KKARNAYLNNSNYEEGDEY (38) and KCC4-AERTEEP-ESPESVDQTSPT (28) encoded within exon 3 of the SLC12A6 gene and exon 1 of the SLC12A7 gene, respectively.
Crude membrane protein was isolated from the renal cortex and medulla, and samples of 100 g were separated by 7.5% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Amersham Pharmacia Biotech). Membranes were blocked for 2 h at room temperature with 10% nonfat dry milk (Bio-Rad) in 150 mM NaCl, 10 mM Tris·HCl, and 0.5% Tween 20 (pH 7.6) (TBST). Membranes were then incubated overnight with rabbit polyclonal antibodies against either KCC3 (1:1,000) or KCC4 antibodies (1:750) in TBST and 5% milk at 4°C. After being washed three times in TBST, membranes were incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibody in blocking solution (1:7,000, GE Healthcare Bioscience). Antigen-antibody complexes on the immunoblots were visualized after an extensive wash using enhanced chemiluminescence (Amersham ECL-Plus systems, GE Healthcare Bioscience).
Immunohistochemistry. Tissues were retrograde perfused via the mesenteric vein with ice-cold PBS and then kept in a vial containing 4% paraformaldehyde until use. Kidneys were removed and embedded in paraffin, and sagittal sections were cut to 1.5 m thickness. Antigen retrieval was performed by incubating the slides in 0.01 mM sodium citrate buffer (pH 6) for 15 min at 80°C. Samples were preincubated for 1 h at room temperature with 0.3% H2O2 in PBS and permeabilized with 0.05% Triton X-100 in PBS for 2 min. Blockade was performed with 1% BSA, 5% FBS, and 0.1% Triton X-100 in PBS for 5 min at room temperature. Samples were then incubated with rabbit anti-KCC4 antibodies (1:200) in the same solution for 45 min at room temperature. Incubation without anti-KCC antibodies served as a negative control. After being washed with 0.1% Triton X-100 in PBS, sections were incubated with the secondary antibody coupled to horseradish peroxidase (donkey anti-rabbit, 1:1,000, Amersham) for 40 min at room temperature. Samples were then washed with 0.1% Triton X-100 in PBS for 10 min and incubated with 0.03% diaminobenzidine tetrahydrochloride as chromogen (Sigma) for 10 min followed by a counterstain with Meyer hematoxylin. Samples were washed in PBS, dehydrated in an ethanol-xylol train, and mounted on coverslips with Permount mounting media (Electron Microscopy Sciences). Slides were observed under ϫ10 and ϫ40 objectives with a bright-light Nikon Eclipse 80i microscope, and images were captured with a Coolpix-4300 Nikon digital camera with four megapixels of resolution.
Immunofluorescence. Rat or mice kidneys were processed for immunofluorescence as described above. Tissue sections (10 m thickness) were incubated for 20 min in PBS with 1% BSA and 4% normal goat serum (NGS) and then incubated with primary antibodies diluted in PBS, BSA, and NGS. An antigen retrieval step was included that required 10 min of incubation in 0.1% SDS diluted in PBS, BSA, and NGS. Sections were rinsed with PBS and NaCl and then with standard PBS. They were then incubated with the KCC4 affinitypurified antibody and diluted in 1% BSA and PBS (1:200) overnight at 4°C. After incubation, sections were washed, incubated with secondary antibodies [FITC-conjugated goat anti-rabbit IgG (1:250, Zymed) or Cy5-labeled anti-rabbit antibody (1:1,000, Molecular Probes)] at room temperature for 1 h, then washed again. To identify acid-secreting ␣-intercalated cells, anti-B1 subunit of H ϩ -ATPase was used as a marker [1:80, gift of Dr. Luna-Arias (34)]. Tissues were mounted on coverslips with Vectashield (Vector Labs). Slides were examined, and images were obtained with a ϫ40 oil-immersion objective mounted on a confocal inverted microscope (Olympus FluoView FV1000). Image analysis was performed using ImageJ software (version 1.36b, National Institutes of Health).
Real-time RT-PCR. Total RNA was extracted from frozen renal cortex and medulla tissue using TRIzol reagent (Invitrogen). Reverse transcription was carried out with 1.0 g of total RNA using 200 units of Moloney murine leukemia virus reverse transcriptase (Invitrogen) and random primers. RNA integrity was analyzed by electrophoresis. KCC3 and KCC4 mRNA were quantified by real-time RT-PCR with the ABI Prism 7300 Sequence Detection System (TaqMan, ABI, Foster City, CA). The ABI TaqMan probes used were KCC3R-XR (5=-GCCTCTCTATCTCGTTCTGTTTTGG-3=) and Rn01537520_m1 (5=-CCATGTGCTGCACCTGTACAATGCT-3=) for KCC3 and KCC4, respectively. As an endogenous control, eukaryotic 18S rRNA was used. Relative quantification of KCC3 and KCC4 gene expression was performed with the comparative threshold cycle (CT) method (32) .
Functional expression of KCC4 in Xenopus laevis oocytes.
We assessed the activity of KCC4 under different extracellular pH conditions using the heterologous expression system of Xenopus laevis oocytes following our previously detailed procedures (9, 35, 37, 38) . In brief, stage V-VI oocytes extracted from anesthetized female frogs were injected with KCC cRNA at 10 ng/oocyte, and, 2 days later, the activity of the cotransporter was determined by assessing Cl Ϫ -dependent 86 Rb ϩ uptake under hypotonic conditions using similar preuptake and uptake solutions that were pH titrated from 6.0 to 8.0. cRNA for injection was transcribed in vitro from KCC4 cDNA linearized at the 3=-end using the T7 RNA polymerase mMESSAGE kit (Ambion).
Statistical analysis. Statistical significance was defined as twotailed P values of Ͻ0.05, and results are presented as means Ϯ SE. The significance of differences between two groups was tested using the Student t-test's; the significance of differences among three or more groups was tested using one-way ANOVA with multiple comparisons using the Bonferroni correction. Table 1 , on the day of euthanization, serum glucose levels were 304 Ϯ 72 mg/dl in the STZ-treated group and 48 Ϯ 9 mg/dl in the control group (P Ͻ 0.001). This was reflected by an increased level of glucose in the urine. Although no differences were observed in serum creatinine or urinary salt excretion between diabetic and control groups, a significant increase in acid and K ϩ secretion was observed in the diabetic group. Hyperglycemic rats exhibited a significant increase in KCC3 expression in the renal cortex at both mRNA and protein levels. As shown in Fig. 1 , expression of KCC3 in the renal cortex was ϳ2.4 Ϯ 0.28-fold higher in hyperglycemic rats than in control rats. This was accompanied by increased expression at the mRNA level. RT-PCR analysis revealed a 1.5 Ϯ 0.19-fold higher level of KCC3 transcripts in the hyperglycemic group than in the control group (P Ͻ 0.05). In contrast, no significant differences in KCC4 protein and mRNA expression were detected in the renal cortex between control and hyperglycemic animals (data not shown). In the renal medulla, however, hyperglycemic animals exhibited a small but nevertheless significant increase in KCC4 protein of 1.2 Ϯ 0.06-fold (P Ͻ 0.05), which was associated with increased expression at the mRNA level of 1.7 Ϯ 0.16-fold (P Ͻ 0.05; Fig. 2 ).
RESULTS

Group 1: animals with STZ-induced diabetes mellitus developed hyperglycemia. As shown in
Group 2: effect of a low-salt diet in mice. As shown in Fig. 3 , Western blot analysis revealed that in whole kidneys from control mice, KCC3 and KCC4 protein expression were very robust. KCC4 was increased by 1.53 Ϯ 0.16-fold (P Ͻ 0.05) in the kidneys of mice fed a low-salt diet, whereas KCC3 expression was not affected. We also assessed the effect of a low-salt diet on KCC3 and KCC4 expression from total kidney proteins in WNK4
Ϫ/Ϫ mice. This enabled us to take advantage of tissue ϩ -Cl Ϫ cotransporter (KCC)3 expression is increased in the renal cortex of hyperglycemic rats. A: Western blot analysis of renal cortex protein lysates from streptozotocin (STZ)-treated (n ϭ 4) or vehicle-treated (n ϭ 4) rats. Blots were exposed to anti-KCC3 affinity-purified antibody, as previously described (38) , or commercially available anti-␤-actin (Santa Cruz Biotechnology). B: densitometric analysis of the blot shown in A. C: mRNA level expression measured through real-time PCR with specific primers for KCC3 (KCC3R-XR: 5=-GCCTCTCTATCTCGTTCTGTTTTGG-3=). *P Ͻ 0.05 vs. control rats.
from animals that were already studied under these experimental conditions in our laboratory and for which the physiological data for exposure to a low-salt diet have already been gathered (8) . Because WNK4 is required for the modulation of renal Na ϩ -Cl Ϫ cotransporter expression by a low-salt diet (8), we analyzed the effect of this experimental maneuver on KCC4 expression in WNK4 Ϫ/Ϫ mice. As shown in Fig. 4 , however, increased expression of KCC4 during salt restriction remained evident in WNK4 Ϫ/Ϫ mice at 1.55 Ϯ 0.11-fold over the control group, suggesting that upregulation of this cotransporter is not dependent on WNK4 activity.
Group 3: metabolic acidosis. To induce metabolic acidosis, male Wistar rats or C57 mice were exposed to NH 4 Cl at a concentration of 280 mM in drinking water for 8 days, which is a known method for inducing this metabolic disturbance (1, 41) . As consistent with previous reports for this model, after 8 days, blood pH, PCO 2 , and HCO 3 Ϫ concentration remained similar between acidotic and control rats (Table 2) . However, animals exposed to NH 4 Cl revealed significantly higher urinary Cl Ϫ excretion and lower urinary pH, indicating the active secretion of protons in the kidney. Mice showed similar differences between control and acidotic animals in urinary pH (acidotic animals: 5.25 Ϯ 0.17 vs. control animals: 6.44 Ϯ 0.36, P Ͻ 0.01). Because our KCC3 and KCC4 antibodies were raised against mouse sequences, cleaner Western blots Fig. 3 . Effect of a low-salt diet in mice. A: Western blot analysis of KCC4 and KCC3 in kidneys from mice exposed to a low-salt (n ϭ 5) or normal salt (control; n ϭ 4) diet. Blots were exposed to anti-KCC4, anti-KCC3, or anti-␤-actin antibodies. B: densitometric analysis of the KCC4 blot shown in A. *P Ͻ 0.05 vs. control mice. C: densitometric analysis of the KCC3 blot shown in A.
Fig. 2. Effect of hyperglycemia on KCC4 expression in the renal medulla.
A: Western blot analysis of renal medulla protein lysates from STZ-treated (n ϭ 4) or vehicle-treated (n ϭ 4) rats. Blots were exposed to anti-KCC4 affinity-purified antibodies, as previously described (28), or anti-␤-actin (Santa Cruz Biotechnology). B: densitometric analysis of the blot shown in A. C: mRNA level expression measured through real-time PCR with specific primers for KCC4 (Rn01537520_m1: 5=-CCATGTGCTGCACCTGTA-CAATGCT-3=). *P Ͻ 0.05 vs. control rats. from total kidney proteins were observed using mouse rather than rat proteins. Thus, Western blot analyses from acidotic mice and their respective control mice are shown in Fig. 5 . The expression of KCC4 was significantly higher in acidotic mice versus their respective control mice. In contrast, no significant changes were observed for KCC3 expression.
Because it has been previously shown that ␣-intercalated cells express KCC4 in the basolateral membrane and that the elimination of this cotransporter in KCC4 knockout mice results in renal tubular acidosis (6, 49), we reasoned that the increased expression of KCC4 in both acidotic and hyperglycemic rats must be in intercalated cells of the collecting duct. To assess this possibility, we first needed to demonstrate that our antibody indeed localized KCC4 in these cells in the rat kidney. Figure 6A shows a collecting duct. Some cells in this duct were positive at the basolateral membrane using the anti-KCC4 antibody and are shown in green. Figure 6B shows that the same cells were positive in the apical membrane (shown in red) using antibodies against the proton pump (34). For KCC4, there was basolateral staining with some intracellular staining. Merge analysis clearly showed that both signals overlapped in the same cell but not in the same membrane, indicating that indeed KCC4 antibodies recognized KCC4 
. Upregulation of KCC4 by a low-salt diet does not require WNK4 expression. A and B: Western blot analysis (A) and densitometric analysis (B) of KCC4 from kidney proteins of WNK4
Ϫ/Ϫ mice exposed to a low-salt (n ϭ 5) or normal salt (control; n ϭ 4) diet. Blots were exposed to anti-KCC4 or anti-␤-actin antibodies. *P Ͻ 0.05 vs. control mice. expression in the basolateral membrane of ␣-intercalated cells (Fig. 6C ). As shown in Fig. 7 , immunohistochemical analysis of sections from the renal outer medulla from animals with hyperglycemia or exposed to NH 4 Cl revealed a similar pattern of increased expression of KCC4 in the basolateral membranes of ␣-intercalated cells compared with control animals. Thus, metabolic acidosis is associated with increased expression of KCC4. Hyperglycemia also resulted in a similar observation. However, this result was unlikely to be due to increased glucose transport because no apical glucose transport occurs in this nephron region. Because hyperglycemia is often associated with metabolic acidosis, we believe that this could be secondary to acidosis, as observed in rats exposed to NH 4 Cl. Finally, the role of KCC4 in the acid secretion capacity of the collecting duct is also supported by the modulation of KCC4 activity by external pH. As shown in Fig. 8 , oocytes injected with KCC4 cRNA, in which 2 days later we assessed Cl Ϫ -dependent 86 Rb ϩ uptake during cell swelling, revealed that the higher the external pH, the lower the KCC4 activity.
Groups 4 and 5: low-and high-K
ϩ diets. Figure 9 shows representative Western blots and the corresponding densitometric analysis of total renal proteins from mice fed with either low-or high K ϩ -diets for 4 days. Proteins were blotted with anti-KCC4 or anti-KCC3 antibodies, with ␤-actin as a loading and transfer control. No effect of changes in K ϩ diet was observed for either KCC4 or KCC3 expression. Fig. 6 . Immunolocalization of KCC4 protein expression in rat kidneys. A: KCC4 antibody detected KCC4 protein (green) at the basolateral membrane of collecting duct cells. B: proton pump antibody labeled (red) the apical membrane of ␣-intercalated cells from the collecting duct. C: dual labeling with KCC4 (FITC secondary) and VATPase-␤ antibody (Cy5 secondary) indicated that KCC4 is expressed in rat ␣-intercalated cells from the collecting duct at the basolateral membrane, whereas the proton pump has an apical localization. Scale bars ϭ 5 m. Fig. 7 . Immunohistochemical analysis of renal outer medulla sections from hyperglycemic and acidotic rats. A and B: kidney slices from STZ-treated (A) and vehicle-treated (B) rats exposed to anti-KCC4 antibody and detection solutions. Magnification: ϫ40. C: semiquantification of KCC4-positive tubules between KCC4 in hyperglycemic compared with control rats. *P Ͻ 0.001 vs. control rats. D and E: kidney slices from acidotic (D) and control (E) rats exposed to anti-KCC4 antibody and detection solutions. Magnification: ϫ40. F: semiquantification of KCC4-positive tubules between KCC4 in NH4Cl-treated compared with control rats. *P Ͻ 0.001 vs. control rats. KCC4 positive tubules are shown by the white arrows.
DISCUSSION
KCCs play important roles in cell volume regulation because they provide a pathway for ion efflux during RVDs in swollen cells (24) . They are also critical for the modulation of the intracellular Cl Ϫ concentration, which is particularly important in neurons because the response to neurotransmitters acting on the postsynaptic ligand-gated Cl Ϫ channel depends on the potential equilibrium of this anion. Additionally, inactivation mutations of KCC3 result in Anderman's syndrome, a severe inherited neurological disease with peripheral neuropathy associated with agenesis of the corpus callosum (12, 25, 45) . Because of this, a tremendous amount of information (10, 14, 22, 36, 45) has been produced in this area since the molecular identification of KCCs (5, 27) . A third fundamental role for KCCs is transepithelial K ϩ and Cl Ϫ transport. The expression of these transporters has been documented in several epithelial cells either at the apical or basolateral membranes (17) . Recent work has suggested an important role for KCC3 and KCC4 in acid secretion in the stomach (13) (14) (15) . KCC3 knockout mice develop arterial hypertension (44) , and KCC4 knockout mice exhibit renal tubular acidosis (6) . Despite these and the known expression of these transporters along the nephron, little is known about their physiological role in the kidney.
In the present study, we analyzed the effect of five different experimental models on the expression of KCC3 and KCC4 because the localization of these transporters along the nephron has already been described (6, 38, 49) and physiological studies (4, 21, 26, 48) have suggested the presence of KCCs in nephron regions and proposed potential roles for these membrane proteins.
We (38) have previously shown that KCC3 is heavily expressed along the basolateral membrane of the PCT and no other region of the nephron exhibits expression of this transporter. In contrast, KCC4, in addition to being expressed in PCT cells, is also present in the basolateral membrane of the TAL and ␣-intercalated cells of the collecting duct (6, 49). Avison et al. (4) observed that in rabbit proximal tubule cells, the addition of glucose to the tubule suspension resulted in a significant increase of intracellular Na ϩ by 30% and a decrease Fig. 8 . KCC4 activity is modulated by external pH (pH0). Xenopus laevis oocytes were injected with 10 ng KCC4 cRNA to assess the effect of pH0 on Cl Ϫ -dependent 86 Rb ϩ uptake during hypotonic conditions. Preuptake and uptake solutions were pH titrated from 6.0 to 8.0. A negative correlation between KCC4-mediated 86 Rb ϩ uptake and pH0 was found (R 2 ϭ 0.94, P Ͻ 0.05). cotransport system in the basolateral membrane of the proximal tubules. In addition, from our characterization of KCCs, we know that K ϩ transport by KCC3 (38) and KCC4 (37) is Ba 2ϩ insensitive and is inhibited by loop diuretics at 1 mM but not at 10 M. We thus reasoned that KCC3 and/or KCC4 could serve as the basolateral KCC system, as both are known to be activated by cell swelling. This provides a pathway to increase the rate of glucose transport, as proposed by the diagrams shown in Fig. 10 . In this scenario, the active entrance of Na ϩ and glucose through the apical membrane, which occurs together with water (33), would be expected to increase the cell volume. This, in turn, activates, probably among others, the basolateral K ϩ -Cl Ϫ pathway that extrudes K ϩ , which help to decrease the intracellular K ϩ concentration. This is done to keep Na ϩ -K ϩ -ATPase activity at maximum because the pump activity is highly sensitive to intracellular K ϩ (3). In a more chronic scenario, it could be possible that in the steady state of chronic hyperglycemia, the swelling effect of apical Na ϩ -glucose cotransport is offset by a loss of water basolaterally due to the 3 Na ϩ out/2 K ϩ in stoichiometry of the pump (the so-called "dehydrating effect of the pump"), an equimolar efflux of glucose, and K ϩ -Cl Ϫ loss via KCC3/KCC4. In this regard, we observed a significant increase in KCC3 but not KCC4 expression at both the mRNA and protein levels in hyperglycemic rats. Thus, our data suggest that it is predominantly KCC3, rather than KCC4, that is the cotransporter providing this regulatory effect in this portion of the kidney nephron. This is supported by the observations of Boettger et al. (7) in a study in which the RVD in isolated perfused proximal straight tubules from wild-type, KCC3
Ϫ/Ϫ , and KCC4 Ϫ/Ϫ mice was compared. After exposure to hypotonicity, wild-type mice increased their cell volume by ϳ10%. RVD was significantly impaired in KCC3 Ϫ/Ϫ mice, whereas it was only marginally affected in KCC4 Ϫ/Ϫ mice. The antibody used in this study recognized both KCC3a and KCC3b variants of KCC3. Therefore, it is not known which one is increased. However, we (38) have previously observed that KCC3b is the predominantly expressed isoform in the kidney. We also showed in that study that there were basically no differences in the functional properties of these isoforms.
Data from in vitro perfused cortical TALs from rabbits allowed Greger and Schlatter (21) to propose the presence of a K ϩ -Cl Ϫ cotransport mechanism in the basolateral membrane. According to the results of immunofluorescence in the kidney, this seems to be KCC4 (6, 49) . In the TAL, virtually all K ϩ enters the cell through the apical Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2) and is recycled to the luminal fluid by apical K ϩ channels, such as the renal outer medullary K ϩ channel (ROMK) (18) . Thus, KCC4 in the basolateral membrane is unlikely to be there for the purpose of transepithelial K ϩ transport. Reasonable possibilities for this are that KCC4 constitutes another pathway for Cl Ϫ extrusion of the cell or that it provides a mechanism for the basolateral extrusion of K ϩ that enters the cell through Na ϩ -K ϩ -ATPase. This would prevent an increase in the intracellular K ϩ concentration that inhibits the activity of the pump. In any case, KCC4 activity would be particularly required when salt reabsorption of the TAL is increased, as during a low-salt diet. Our data revealed a significant upregulation of KCC4 expression in total protein lysates of mice exposed to a low-salt diet. This observation suggests that KCC4 could be the cotransporter responsible for the previous proposal (21) , that under activation of TAL salt transport capacity, a KCC plays a role in the cell's K ϩ and Cl Ϫ extrusion (Fig. 10) . Based on our data suggesting that KCC4 plays a role in salt reabsorption of the TAL, KCC4 could be a potential explanation for the difference in the age of onset of Bartter's syndrome type I or II, which begins at birth or before as polyhydramnios. This is in contrast to type III, which usually becomes apparent in the first year of life or later (22) . Types I and II are due to inactivating mutations of NKCC2 and ROMK, respectively, which completely prevent salt reabsorption in the TAL. Type III is due to mutations in the basolateral Cl Ϫ channel CLC-KB, which prevents Cl Ϫ extrusion from the cell and eventually reduces the activity of NKCC2 because this transporter is highly sensitive to the intracellular Cl Ϫ concentration (43). Hence, it is possible that KCC4 activity is able to maintain the intracellular Cl Ϫ concentration at a level that allows some activity of NKCC2 for some time after birth in children with Barrett's syndrome type III.
Regulation of the thiazide-sensitive Na ϩ -Cl Ϫ cotransporter during a low-salt diet and/or angiotensin II infusion is dependent on the presence of WNK4 kinase (8) . The WNK4-induced inhibitory effect on the Na ϩ -Cl Ϫ cotransporter is switched to stimulatory in the presence of angiotensin II (46) . Because KCC4 activity is also inhibited by WNK4 (19), we took advantage of our WNK4 total knockout mouse model to explore whether the observed upregulation in a low-salt diet could also be dependent on WNK4. However, we observed that upregulation of KCC4 expression occurred in WNK4 Ϫ/Ϫ mice similar to that in wild-type mice, indicating that this kinase is not required.
Our data support the proposal that KCC4 plays an important role in acid-base metabolism in the kidney. This was originally suggested by the fact that KCC4 knockout mice develop renal tubular acidosis (6) . The expression of KCC4 at the basolateral membrane of ␣-intercalated cells was increased in rats exposed to NH 4 Cl in drinking water and in hyperglycemic rats, which are known to be associated with a certain degree of metabolic acidosis. Additionally, the activity of KCC4 strongly negatively correlates with higher extracellular pH. Lower pH correlates with higher KCC activity (Fig. 8) . Thus, our data are consistent with the model proposed by Boettger et al. (6) : that KCC4 in the basolateral membrane of ␣-intercalated cells of the collecting duct could be critical for keeping the intracellular concentration of Cl Ϫ low so that basolateral Cl Ϫ /HCO 3 Ϫ exchanger remains active. This serves to extrude HCO 3 Ϫ from the cell, allowing the continuous production of H ϩ to be secreted in the apical membrane (Fig. 10) .
A previous study (47) has shown that KCC1 expression at the basolateral membrane of the colonic epithelium is increased during a low-K ϩ diet, suggesting that KCC1 might play a role in K ϩ absorption in this circumstance. We found, however, no change in KCC3 or KCC4 expression in the kidney after exposing mice to both low-and high-K ϩ diets, suggesting that these cotransporters probably are not involved in the renal response to changes in dietary K ϩ , in which the roles of K ϩ channels have been extensively demonstrated (23) . Finally, a potential role for a KCC transporter in the DCT remains to be elucidated. Amorim et al. (2) obtained evidence for a K ϩ -Cl Ϫ cotransport mechanism in the apical membrane of the DCT that could be of particular importance to K ϩ secretion during low Cl Ϫ concentration states. However, expression of neither KCC3 nor KCC4 was observed in the apical membrane of the DCT. One possibility is that KCC1 could be the transporter responsible for this observation, but no detailed analysis using an anti-KCC1 antibody has been performed in renal tissue.
In summary, our data are consistent with proposals stating that specific KCCs play a role in glucose, salt, and acid-base metabolism in the kidney.
